Cargando…

Clinical application of biological markers for treatments of resectable non-small-cell lung cancers

We performed a clinical study to identify biological markers useful for the treatment of resectable non-small-cell lung cancers (NSCLCs). In all, 173 patients were studied. By immunohistochemistry, we evaluated the Ki-67 proliferation index, tumour vascularity, thymidylate synthase (TS), vascular en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, C, Liu, D, Masuya, D, Nakashima, T, Kameyama, K, Ishikawa, S, Ueno, M, Haba, R, Yokomise, H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361974/ https://www.ncbi.nlm.nih.gov/pubmed/15785747 http://dx.doi.org/10.1038/sj.bjc.6602481

Ejemplares similares

The tumour–stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients
por: Masuya, D, et al.
Publicado: (2004)

Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients
por: Nakashima, T, et al.
Publicado: (2003)

The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers
por: Nakano, J, et al.
Publicado: (2008)

Evaluations of biomarkers associated with 5-FU sensitivity for non-small-cell lung cancer patients postoperatively treated with UFT
por: Nakano, J, et al.
Publicado: (2006)

Preoperative monocyte count is a predictor of recurrence after Stage I lung adenocarcinoma resection
por: Yoshida, Chihiro, et al.
Publicado: (2022)

Angiogenic Response to Major Lung Resection for Non-Small Cell Lung Cancer with Video-Assisted Thoracic Surgical and Open Access
por: Ng, Calvin S. H., et al.
Publicado: (2012)

Surgical Resection for Small Cell Lung Cancer: Pneumonectomy versus Lobectomy
por: Yuequan, Jiang, et al.
Publicado: (2012)

Randomised study of adjuvant chemotherapy for completely resected p-stage I–IIIA non-small cell lung cancer
por: Nakagawa, K, et al.
Publicado: (2006)

Completely Resected N0 Non-Small Cell Lung Cancer: Prognostic Factors Affecting Long-Term Survival
por: Tantraworasin, Apichat, et al.
Publicado: (2013)

Circadian function in patients with advanced non-small-cell lung cancer
por: Levin, R D, et al.
Publicado: (2005)

Baseline tumour measurements predict survival in advanced non-small cell lung cancer
por: Gerber, D E, et al.
Publicado: (2013)

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study
por: Betticher, D C, et al.
Publicado: (2006)

The application of fluorescein sodium for the resection of medulloblastoma
por: Chen, Zheng-he, et al.
Publicado: (2022)

Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit
por: Khakwani, A, et al.
Publicado: (2013)

Biological Reconstruction Following the Resection of Malignant Bone Tumors of the Pelvis
por: Traub, Frank, et al.
Publicado: (2013)

Lobectomy versus Sublobar Resection in Non-Lepidic Small-Sized Non-Small Cell Lung Cancer
por: Namkoong, Min, et al.
Publicado: (2017)

Current status and perspectives of spread through air spaces in lung cancer
por: Ikeda, Toshihiro, et al.
Publicado: (2021)

Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer
por: Pinato, D J, et al.
Publicado: (2014)

Endoscopic Resection for Small Rectal Neuroendocrine Tumors: Comparison of Endoscopic Submucosal Resection with Band Ligation and Endoscopic Submucosal Dissection
por: Bang, Byoung Wook, et al.
Publicado: (2016)

Montreal prognostic score: estimating survival of patients with non-small cell lung cancer using clinical biomarkers
por: Gagnon, B, et al.
Publicado: (2013)

Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma
por: Iida, S, et al.
Publicado: (2013)

Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer
por: Gagnon, B, et al.
Publicado: (2010)

The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers
por: Atherly, A J, et al.
Publicado: (2012)

Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I–II trial
por: Stathopoulos, G P, et al.
Publicado: (2005)

Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival
por: Nisman, B, et al.
Publicado: (2008)

Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer
por: Leighl, N B, et al.
Publicado: (2008)

RNF128 expression in lung adenocarcinoma is a favorable prognostic factor associated with decreased tumor‐associated macrophages
por: Fujimoto, Syuusuke, et al.
Publicado: (2023)

Non-small-cell lung cancer in a French department, (1982–1997): management and outcome
por: Foeglé, J, et al.
Publicado: (2005)

Endothelial Glycocalyx Layer: A Possible Therapeutic Target for Acute Lung Injury during Lung Resection
por: Wang, JiaWan, et al.
Publicado: (2017)

Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy
por: Grossi, F, et al.
Publicado: (2017)

Innovative method using circulating tumor cells for prediction of the effects of induction therapy on locally advanced non-small cell lung cancer
por: Tarumi, Shintaro, et al.
Publicado: (2013)

A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy
por: Kotsakis, A, et al.
Publicado: (2016)

Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809
por: Niho, S, et al.
Publicado: (2013)

Pulmonary Bacterial Communities in Surgically Resected Noncystic Fibrosis Bronchiectasis Lungs Are Similar to Those in Cystic Fibrosis
por: Maughan, Heather, et al.
Publicado: (2012)

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients
por: Cappuzzo, F, et al.
Publicado: (2005)

Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer
por: Scagliotti, G V, et al.
Publicado: (2006)

Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer
por: Nishio, M, et al.
Publicado: (2013)

A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index
por: Colinet, B, et al.
Publicado: (2005)

Bilateral Fibular Graft: Biological Reconstruction after Resection of Primary Malignant Bone Tumors of the Lower Limb
por: Niethard, Maya, et al.
Publicado: (2013)

Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party
por: Berghmans, T, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_92b25uqe16bgn84bm4gpgje07o